GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CES1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARA, PPARG, RORC, SLC6A2, SLC6A4, SRC, TERT, TYR |
10.016 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
9.57654 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.57654 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
9.57236 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, FABP3, FABP4, FUT7, HMGCR, HSD17B2, MET, PPARA, PPARG |
9.19025 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP2, PPARA, PPARG, RORC, SLC6A4, SRC, TYR |
8.73053 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, FABP3, HMGCR, HSD17B2, HSP90AB1, IGF1R, MMP2, MMP9, PPARA, PPARG, RORC, SLC6A4, SRC, TYR |
8.73053 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, FUT7, GLO1, HMGCR, PIM1, PPARA, PPARG, TYR, XDH |
8.64237 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, ALPI, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, FABP3, FABP4, FUT7, HMGCR, MET, PPARA, PPARG |
7.57824 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, ESR1, HMGCR, HSD17B2 |
7.48838 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HMGCR, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
7.48838 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CES1, CYP1A1, CYP1B1, DRD2, HMGCR, HSP90AA1, KDR, SLC6A4, SRC |
7.31278 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
7.22827 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, HSP90AB1, RORC |
6.89808 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, FLT3, HSP90AB1, PPARG, RORC, SLC6A4, SRC, TYR |
6.89808 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARG, RORC, SLC6A4, SRC, TERT |
6.88727 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, PPARA, PPARG |
6.72766 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC, TERT |
6.70163 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, HTR1A, KCNH2, KDR, MET, PPARA, PPARG, SLC6A2, SLC6A4, SRC, TERT, XDH |
6.50154 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, HMGCR, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
6.38859 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CDC25B, CES1, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HSP90AB1, KDR, MET, MMP2, MMP9, PIM1, PPARA, PPARG, RORC, SLC6A4, SRC, TERT, TOP2A, TYR |
6.23356 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADRA2A, AKR1B1, BCL2, CDC25B, CYP1B1, DRD2, ESR1, ESRRA, FABP3, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PPARG, SLC6A4, SRC, TERT, XDH |
6.23356 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, HMGCR, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PPARG, PTPN1, SRC, TERT, TOP2A, XDH |
6.21992 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
6.20531 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD17B2, PPARG, RORC, SLC6A4, SRC, TYR |
6.18993 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
6.11424 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, HMGCR, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, PPARG, PTPN1, SRC, TERT, TOP2A, XDH |
6.10473 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, FABP3, HMGCR, HSP90AB1, KCNH2, KDR, PPARG, SLC6A2, SLC6A4, SRC |
6.10473 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
6.04164 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
6.03745 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADRA2A, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CES1, CHRM2, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KCNH2, KDR, MMP12, MMP2, MMP9, PPARA, PPARG, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TYR |
5.95465 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CYP1A2, ESR1, ESRRA, FABP3, FLT3, PPARA, PPARG, SLC6A4, SRC |
5.87012 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, HMGCR, HSD17B2, PPARG, TYR, XDH |
5.81906 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GLO1, PPARA, PPARG |
5.67711 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRB, FABP4, HMGCR, HSD17B2, HTR1A, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SLC6A2, SLC6A4, SRC, TYR |
5.66682 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, PPARG, RORC, SRC |
5.60765 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.57115 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, APEX1, AURKB, AXL, BCL2, CYP1B1, ESR1, FLT3, GLO1, HMGCR, HSP90AB1, IGF1R, KDR, MMP9, PIM1, PPARG, PTPN1, SRC, TERT, TOP2A, XDH |
5.52591 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, PPARG, RORC, SLC6A4, SRC |
5.51923 |
[BP] GO:0042592 |
homeostatic process
|
ADRA2A, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, DRD2, ESR1, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, KCNH2, MET, PPARG, SRC, TERT |
5.51923 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC, SRC |
5.40829 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CYP1A2, ESR1, ESRRA, FABP3, FLT3, IGF1R, MMP2, PPARA, PPARG, SLC6A4, SRC |
5.32551 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, ESR1, FLT3, HSP90AB1, PPARG, RORC, SLC6A4, SRC |
5.19009 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KCNH2, KDR, MMP2, MMP9, PPARG, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A |
5.19009 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, BCL2, CDC25B, DRD2, ESR1, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, TERT |
5.15925 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.13267 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
5.11912 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, DRD2, ESR1, PPARA, PPARG, RORC, SLC6A4, SRC, TOP2A |
5.02539 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSP90AB1, KDR, PPARA, PPARG, SRC, TYR |
4.98072 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
4.89984 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HMGCR, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TERT |
4.78106 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC, SRC |
4.65985 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GLO1, PIM1, PPARA, PPARG, TYR |
4.56697 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, DRD2, HMGCR, HTR1A, TYR |
4.55784 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HMGCR, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TERT |
4.51302 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HMGCR, HSP90AB1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
4.51302 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.51302 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD2, HMGCR, HSP90AA1, HSP90AB1, MMP2, PPARA, PPARG, SLC6A4, SRC, TERT, TYR |
4.51302 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.45528 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRA2A, AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, HSP90AB1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
4.32493 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRA2A, AKR1B1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, FLT3, HMGCR, HSP90AB1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
4.29996 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, FABP3, FABP4, FUT7, HSP90AA1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.26119 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GLO1, PIM1, PPARA, PPARG, TYR |
4.07132 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, SRC, TERT |
4.05837 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADRA2A, APEX1, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, HMGCR, HSP90AB1, HTR1A, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PPARA, PPARG, PTPN1, SLC6A4, SRC, TERT |
4.04442 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRA2A, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HMGCR, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARG, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
4.02561 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FABP3, GLO1, PIM1, PPARA, PPARG, TYR |
3.99177 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADRA2A, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARG, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
3.98798 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, PPARG, SLC6A4, SRC, TERT |
3.98465 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRA2A, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HMGCR, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARG, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
3.94774 |
[BP] GO:0051972 |
regulation of telomerase activity
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
3.90697 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, GLO1, HMGCR, HSP90AB1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TERT |
3.88438 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADRA2A, BCL2, DRD2, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PPARG, PTPN1, SLC6A4, SRC, TERT, XDH |
3.88438 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADRA2A, BCL2, DRD2, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PPARG, PTPN1, SLC6A4, SRC, TERT, XDH |
3.8697 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRA2A, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARG, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
3.80016 |
[BP] GO:0080134 |
regulation of response to stress
|
ADRA2A, CYP19A1, DRD2, ESR1, FABP4, HMGCR, HSP90AA1, HSP90AB1, IGF1R, MET, MMP12, MMP2, PPARA, PPARG, PTPN1, SRC, TERT, XDH |
3.79971 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HMGCR, HSD17B2, HTR1A |
3.79026 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, ESR1, ESR2, FLT3, HMGCR, HSP90AB1, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PPARG, PTPN1, SLC6A4, SRC, TERT, XDH |
3.74055 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
3.71592 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC |
3.71592 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, DRD2, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, SLC6A4, SRC, TYR |
3.69671 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, FABP3, PPARA, PPARG |
3.68172 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRA2A, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CYP19A1, CYP1B1, DRD2, ESR1, ESR2, FLT3, HMGCR, HSP90AB1, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PPARG, PTPN1, SLC6A4, SRC, TERT, XDH |
3.65106 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.65005 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.65005 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADRA2A, AKR1B1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HMGCR, HSP90AB1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
3.64726 |
[BP] GO:0030334 |
regulation of cell migration
|
ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PPARG, SRC, TERT |
3.64726 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADRA2A, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, HMGCR, HSP90AB1, HTR1A, KCNH2, MMP12, MMP9, PPARA, PPARG, PTPN1, SLC6A4, SRC, TERT |
3.62397 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD17B2, HSP90AB1, MMP2, MMP9, PPARG, SLC6A4, SRC, TOP2A |
3.61737 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.57068 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.57068 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.57068 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CDC25B, CES1, CYP1A1, DRD2, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, HMGCR, KDR, MET, MMP2, MMP9, PPARG, RORC, SRC, TERT, TOP2A |
3.55737 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.53042 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, PPARG, SRC, TERT |
3.50363 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, HSP90AA1, HSP90AB1, HTR1A, SLC6A2, SLC6A4 |
3.48985 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.44285 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, PPARG, RORC |
3.42459 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, DRD2, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, SLC6A4, SRC, TYR |
3.40331 |
[BP] GO:2000145 |
regulation of cell motility
|
ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PPARG, SRC, TERT |
3.39493 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADRA2A, AXL, BCL2, CA2, CYP19A1, DRD2, HSP90AB1, KCNH2, MMP12, PPARG, SLC6A4, SRC, TERT |
3.38639 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B2 |
3.38615 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.37377 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SLC6A4, SRC, TERT |
3.37047 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADRA2A, CYP1A1, FABP3, FLT3, HMGCR, PPARA, PPARG, RORC, SRC |
3.34378 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CES1, CES2, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
3.34378 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSP90AB1, PPARG, SRC |
3.34378 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.34316 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, DRD2, FLT3, HMGCR, HSP90AA1, IGF1R, KCNH2, KDR, MET, PIM1, PTPN1, SRC, XDH |
3.33874 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR |
3.31146 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, DRD2, HSP90AB1, SLC6A4, SRC, TERT |
3.28238 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPI, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CYP1A1, CYP1A2, DRD2, ESR1, FLT3, FUT7, GLO1, HMGCR, HSP90AA1, HTR1A, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, SRC, TOP2A, TYR, XDH |
3.28238 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HMGCR |
3.27714 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, ESRRA, FABP4, FLT3, HMGCR, HSP90AA1, HSP90AB1, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TERT, XDH |
3.25889 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP12, PPARA, PPARG, RORC, SRC, TERT, TOP2A |
3.25889 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSP90AB1, PPARG, SRC |
3.24395 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, HSP90AB1, KCNH2, KDR, SRC |
3.23379 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, PPARG, TERT |
3.23187 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, AXL, BCL2, CA2, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSP90AB1, KDR, MMP9, PIM1, PPARA, PPARG, RORC, SRC, TYR |
3.18809 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADRA2A, BCL2, CYP19A1, DRD2, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PPARG, PTPN1, SRC, TERT, XDH |
3.18486 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADRA2A, AURKB, CYP1B1, DRD2, ESR1, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PPARG, PTPN1, SRC |
3.17738 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, DRD2, ESR1, ESR2, ESRRA, ESRRB, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP12, PPARA, PPARG, RORC, SRC, TERT, TOP2A |
3.17438 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC |
3.15357 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.14607 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, TERT |
3.14607 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, BCL2, DRD2, ESR1, ESR2, HMGCR, IGF1R, MET, MMP12, MMP9, PPARG, PTPN1, SRC, TERT, XDH |
3.11049 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, ESR1, IGF1R, MMP2, MMP9, PPARG, RORC, SLC6A4, SRC |
3.10621 |
[BP] GO:0040012 |
regulation of locomotion
|
ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PPARG, SRC, TERT |
3.10621 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, HTR1A, TYR |
3.10621 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, FLT3, HMGCR, HSP90AB1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TERT, XDH |
3.10621 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, DRD2, FLT3, HMGCR, HSP90AA1, IGF1R, KCNH2, KDR, MET, PIM1, PTPN1, SRC, XDH |
3.09851 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADRA2A, APEX1, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, PPARG, SRC, TERT |
3.09846 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, ESR1, HMGCR, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
3.03754 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
3.02165 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AURKB, DRD2, ESR1, ESR2, ESRRA, ESRRB, HSP90AA1, HSP90AB1, IGF1R, MET, MMP12, PPARA, PPARG, PTPN1, RORC, SRC, TERT, TOP2A |
2.99911 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, DRD2 |
2.96772 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, MET, PIM1, SRC, TYR |
2.94686 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, TERT |
2.90812 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PPARG, SLC6A4, SRC |
2.88601 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.88601 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, BCL2, CA12, CA2, CA7, DRD2, ESR1, FABP3, FABP4, KCNH2, MET, PPARG |
2.87471 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, FABP3, PPARA, PPARG |
2.86986 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, HMGCR, PPARG, SLC6A4, SRC, TYR |
2.85137 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRA2A, BCL2, CDC25B, DRD2, ESRRB, FABP3, FLT3, HMGCR, HSP90AB1, KDR, MMP9, PTPN1, SRC, XDH |
2.85137 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRA2A, BCL2, CDC25B, DRD2, ESRRB, FABP3, FLT3, HMGCR, HSP90AB1, KDR, MMP9, PTPN1, SRC, XDH |
2.85137 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.84388 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HSP90AA1, HSP90AB1, IGF1R, MET, MMP12, PPARA, PPARG, RORC, SRC, TERT, TOP2A |
2.84155 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRA2A, AKR1B1, AXL, BCL2, CYP1B1, DRD2, FLT3, HMGCR, KDR, MET, PTPN1, SRC, XDH |
2.74211 |
[BP] GO:0042752 |
None
|
DRD2, PPARA, PPARG, RORC, TOP2A |
2.68827 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADRA2A, BCL2, CDC25B, DRD2, ESRRB, FLT3, HMGCR, HSP90AB1, KDR, MMP9, PTPN1, SRC, XDH |
2.68827 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.67704 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADRA2A, BCL2, CDC25B, DRD2, ESRRB, FABP4, FLT3, HMGCR, HSP90AB1, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.59111 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADRA2A, AURKB, CDC25B, DRD2, FABP4, FLT3, HMGCR, HSP90AA1, HSP90AB1, IGF1R, PPARG, PTPN1, SRC |
2.5862 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADRA2A, AXL, BCL2, CA2, CHRM2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, HMGCR, HSP90AB1, KCNH2, KDR, MET, MMP12, MMP9, PIM1, PPARG, SLC6A4, SRC, TERT, XDH |
2.5862 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APEX1, AURKB, BCL2, DRD2, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSP90AB1, IGF1R, MET, MMP12, MMP9, PPARA, PPARG, PTPN1, RORC, SRC, TERT, XDH |
2.58554 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADRA2A, AURKB, BCL2, CA2, CA7, DRD2, HMGCR, KDR, SRC |
2.57098 |
[BP] GO:2000278 |
regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
2.56963 |
[BP] GO:0007004 |
None
|
HSP90AA1, HSP90AB1, TERT |
2.54153 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
2.53426 |
[BP] GO:0060249 |
None
|
AKR1B1, APEX1, BCL2, HSP90AA1, HSP90AB1, SRC, TERT |
2.5309 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, AXL, BCL2, CA2, CYP1B1, DRD2, ESRRB, HMGCR, KDR, MET, MMP12, MMP9, PIM1, PPARG, SRC, TERT |
2.51126 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.48842 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.48842 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.48842 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADRA2A, APEX1, AURKB, BCL2, DRD2, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSP90AB1, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PPARG, PTPN1, RORC, SRC, TERT, XDH |
2.46281 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRA2A, BCL2, CDC25B, DRD2, ESRRB, FABP3, FABP4, FLT3, HMGCR, HSP90AB1, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.44781 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADRA2A, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, MET, MMP9, PPARG, PTPN1, SRC, TERT, XDH |
2.42876 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRA2A, BCL2, CDC25B, DRD2, ESRRB, FABP3, FABP4, FLT3, HMGCR, HSP90AB1, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.41129 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADRA2A, AKR1B1, AURKB, AXL, BCL2, CYP19A1, CYP1B1, DRD2, ESR1, ESR2, ESRRA, FABP4, FLT3, HMGCR, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PPARG, PTPN1, SRC, TERT, XDH |
2.39547 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CDC25B, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, FUT7, GLO1, HMGCR, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH |
2.39547 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CYP1A1, HMGCR, PPARG, SLC6A4, TYR |
2.38629 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.37568 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, IGF1R, KDR, PIM1, SRC |
2.35464 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.33876 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.32989 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, DRD2, ESR1, FABP4, HSP90AB1, MMP12, MMP2, PPARA, PPARG, PTPN1, SRC |
2.32337 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.32306 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.32306 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, FLT3, HSP90AA1, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.3219 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PPARG, SRC |
2.30057 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, HMGCR, PPARG, SLC6A4, SRC, TYR |
2.29599 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADRA2A, BCL2, CDC25B, DRD2, FLT3, HMGCR, HSP90AB1, KDR, MMP9, PTPN1, SRC, XDH |
2.28482 |
[BP] GO:0030154 |
cell differentiation
|
ALPL, AXL, BCL2, CES1, CYP1A1, ESR1, FABP4, FLT3, FUT7, GLO1, HMGCR, KDR, MMP2, MMP9, PPARG, RORC, TOP2A |
2.2795 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.27619 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, SRC |
2.26785 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HMGCR, HSD17B2 |
2.26155 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AOX1, APEX1, BCL2, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, ESR2, ESRRA, ESRRB, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, HTR1A, PPARA, PPARG, RORC, TERT, TOP2A, TYR, XDH |
2.25282 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.25282 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRA2A, AKR1B1, AURKB, AXL, BCL2, CYP1B1, DRD2, ESR1, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
2.25282 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, HSP90AA1, HSP90AB1, HTR1A, MMP2, MMP9, PPARA, PPARG, PTPN1, SLC6A2, SLC6A4, SRC, TERT, TOP2A |
2.25282 |
[BP] GO:1905323 |
None
|
HSP90AA1, HSP90AB1 |
2.25282 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.25282 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25282 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD2, KDR, SRC |
2.25282 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B2 |
2.24375 |
[BP] GO:0035902 |
response to immobilization stress
|
CYP1A1, CYP1A2, PPARG |
2.24375 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.24375 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.22703 |
[BP] GO:0014910 |
regulation of smooth muscle cell migration
|
APEX1, BCL2, SRC, TERT |
2.22076 |
[BP] GO:0015908 |
None
|
DRD2, FABP3, PPARA, PPARG |
2.22076 |
[BP] GO:0045088 |
regulation of innate immune response
|
DRD2, ESR1, HSP90AB1, MMP12, MMP2, PPARG, PTPN1, SRC |
2.18967 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, ESR1, FLT3, IGF1R, MMP2, PPARG, SLC6A4, SRC |
2.18759 |
[BP] GO:0010833 |
None
|
HSP90AA1, HSP90AB1, TERT |
2.15046 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, HSP90AA1, KDR, SRC |
2.10526 |
[BP] GO:0006278 |
None
|
HSP90AA1, HSP90AB1, TERT |
2.10526 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, BCL2, CDC25B, CYP1A1, DRD2, HSP90AA1, HSP90AB1, PIM1, SLC6A4, SRC, TERT, TOP2A |
2.0897 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.0897 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, BCL2, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.08616 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADRA2A, BCL2, DRD2, KCNH2, MMP9 |
2.07746 |
[BP] GO:0051172 |
None
|
ADRA2A, APEX1, AURKB, DRD2, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSP90AB1, IGF1R, MMP12, MMP9, PPARA, PPARG, PTPN1, RORC, SRC, TERT, XDH |
2.07407 |
[BP] GO:0046320 |
None
|
FABP3, PPARA, PPARG |
2.07407 |
[BP] GO:0032800 |
receptor biosynthetic process
|
ACHE, PPARG |
2.07407 |
[BP] GO:0010891 |
None
|
PPARA, PPARG |
2.07407 |
[BP] GO:0032845 |
None
|
ADRA2A, BCL2, DRD2, HMGCR, SRC |
2.04779 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, HMGCR, TERT |
2.04779 |
[BP] GO:0007193 |
None
|
ADRA2A, CHRM2, DRD2, HTR1A |
2.04047 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, BCL2, IGF1R, KDR, MET, MMP9, SRC, TERT |
2.00008 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CES1, CES2, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, KCNH2, KDR, MMP2, MMP9, PIM1, PPARG, PTPN1, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
2.57638 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FLT3, HMGCR, HSD17B2, PTPN1 |
2.23208 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
1.95012 |
[CC] GO:0016020 |
membrane
|
ACHE, ADRA2A, ALOX5, ALPI, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KCNH2, KDR, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SRC, TERT, TYR |
1.94398 |
[CC] GO:0005783 |
None
|
APEX1, BCL2, CA4, CES1, CES2, CYP19A1, FLT3, HMGCR, KDR, PTPN1, XDH |
1.80987 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, ALPI, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, TYR, XDH |
17.3011 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HMGCR, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TYR, XDH |
12.3116 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, ESR2, ESRRA, ESRRB, GLO1, HTR1A, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TOP2A, TYR, XDH |
9.57654 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, FLT3, FUT7, GLO1, HMGCR, HSD17B2, HSP90AA1, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TERT, TOP2A, TYR, XDH |
8.38248 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.06958 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A2, SLC6A4, TERT, TOP2A, TYR, XDH |
7.93873 |
[MF] GO:0008270 |
zinc ion binding
|
ALPI, CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, PPARG, PTPN1, RORC |
7.90476 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, XDH |
6.9117 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.72766 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC |
6.72766 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC |
6.72766 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, TYR |
6.23356 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG, RORC |
6.23356 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, HMGCR, HSD17B2, TYR, XDH |
6.13222 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, DRD2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PPARA, PPARG, SLC6A4, SRC, TOP2A |
5.89575 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, BCL2, DRD2, ESR1, ESR2, FLT3, HMGCR, HSP90AA1, HSP90AB1, IGF1R, KCNH2, KDR, MET, MMP9, PPARG, SLC6A4, TERT, TOP2A, TYR, XDH |
5.66199 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7 |
5.66199 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19 |
5.52591 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, SRC |
5.44745 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.40829 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, SRC |
5.21866 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.07641 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, BCL2, DRD2, FLT3, HMGCR, HSP90AA1, HSP90AB1, KCNH2, SLC6A4, TERT, TOP2A, TYR, XDH |
4.98072 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADRA2A, APEX1, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SRC |
4.98072 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, TYR |
4.89984 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19 |
4.60975 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADRA2A, APEX1, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
4.57654 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, GLO1 |
4.38825 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, ALPI, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, ESR1, ESR2, ESRRB, HMGCR, HSP90AA1, HSP90AB1, KCNH2, MET, PPARA, PPARG, PTPN1, SLC6A4, SRC, TOP2A |
4.27092 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADRA2A, AOX1, AXL, BCL2, DRD2, FLT3, HMGCR, HSP90AA1, HSP90AB1, KCNH2, PPARG, SLC6A4, TERT, TOP2A, TYR, XDH |
3.98766 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, HMGCR, SRC, XDH |
3.98103 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
ESR1, HSP90AA1, HSP90AB1 |
3.65005 |
[MF] GO:0038023 |
signaling receptor activity
|
ADRA2A, AXL, CHRM2, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HTR1A, IGF1R, KCNH2, KDR, MET, PPARA, PPARG, RORC |
3.55737 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.49268 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.43307 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HMGCR, HSD17B2, XDH |
3.10621 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.08683 |
[MF] GO:0004872 |
receptor activity
|
ADRA2A, AXL, CHRM2, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HTR1A, IGF1R, KCNH2, KDR, MET, PPARA, PPARG, RORC |
2.98481 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, RORC |
2.92319 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.88601 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.88601 |
[MF] GO:0060089 |
molecular transducer activity
|
ADRA2A, AXL, CHRM2, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HTR1A, IGF1R, KCNH2, KDR, MET, PPARA, PPARG, RORC |
2.84155 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.81152 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, HMGCR, MET, PPARA, PPARG, PTPN1 |
2.71345 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADRA2A, AOX1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KDR, MET, MMP12, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
2.66442 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, BCL2, ESR1, ESRRB, FLT3, PIM1, PPARA, PPARG, SRC, TERT |
2.60496 |
[MF] GO:0008392 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.60257 |
[MF] GO:0008391 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.60257 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.51893 |
[MF] GO:0004871 |
signal transducer activity
|
ADRA2A, AXL, CHRM2, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HTR1A, IGF1R, KCNH2, KDR, MET, PPARA, PPARG, RORC |
2.51537 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.48842 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.48842 |
[MF] GO:0008227 |
None
|
ADRA2A, CHRM2, DRD2, HTR1A |
2.42876 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.42876 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, HMGCR, MET, PPARG, PTPN1 |
2.36989 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, FLT3, HSP90AA1, IGF1R, KCNH2, KDR, MET, PIM1, SRC |
2.30464 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.25282 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, PPARA, PPARG, RORC |
2.22076 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARG |
2.10526 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, HTR1A, SLC6A4 |
2.0897 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.07407 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.07407 |
[MF] GO:0052689 |
carboxylic ester hydrolase activity
|
ACHE, CA1, CA2, CES1, CES2 |
2.07407 |
[MF] GO:1901363 |
heterocyclic compound binding
|
AOX1, APEX1, AURKB, AXL, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSP90AA1, HSP90AB1, HTR1A, IGF1R, KDR, MET, MMP12, PIM1, PPARA, PPARG, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, XDH |
2.03496 |